CLINICAL_TRIALS
trial_result
· 2011-07-13
Clinical Trial Update: Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Genfit completed a Phase 2 trial comparing GFT505 (80 mg) to placebo in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genfit | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: COMPLETED